18/07/2025
๐ ๐๐
๐ฝ๐ฎ๐ป๐ฑ๐ถ๐ป๐ด ๐๐ฐ๐ฐ๐ฒ๐๐ ๐๐ผ ๐๐น๐ผ๐ผ๐ฑ ๐๐ถ๐๐ผ๐ฟ๐ฑ๐ฒ๐ฟ๐ ๐๐ฎ๐ฟ๐ฒ ๐ถ๐ป ๐๐ฎ๐๐ ๐๐ณ๐ฟ๐ถ๐ฐ๐ฎ! ๐
We are honoured to share our project impact report, showcasing the incredible results achieved through our collaboration with partners in Rwanda, Uganda, Tanzania, and Kenya. With the support of the Novo Nordisk Foundation and the Novo Nordisk Haemophilia Foundation, we have made significant strides in strengthening haemophilia and sickle cell disease care across the region.
๐ฉธ 2,246 individuals with haemophilia and 2,227 with sickle cell disease benefited from our initiatives
๐ฌ 538 people retested or newly diagnosed
๐ 28 centres established/strengthened
๐ฉบ 667 healthcare professionals trained
๐ฅ 600 youth empowered
The work that started in 2023 has led to a 28% increase in diagnosis rates and up to a 10-hour reduction in travel time for care. National treatment guidelines have been endorsed in Rwanda and Tanzania, and a Centre of Excellence has been established in Kenya.
And the work continuesโฆ This past Wednesday, representatives from partner countries, along with a special guest from India showcasing success stories, gathered to launch a new phase of cross-country collaboration. This initiative focuses on enhancing integrated care for haemophilia and sickle cell disease through care strengthening, awareness, and data-driven advocacy. Stay tuned for more updates. Exciting times ahead!
Our heartfelt thank you ๐ to our partners, volunteers and funders who have helped achieve this!
We invite you to dive into our project report and discover more of the remarkable work of our partners to improve access to care:https://nnhf.org/wp-content/uploads/2025/07/NNHF_Report-East-Africa_v4.pdf
Together, we are building a brighter future for those affected by blood disorders in East Africa. ๐ค๐